Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Vesela
Ds3 - Regorafenib in Metastatic Colorectal Cancer: Cost-Effectiveness Analysis Based on Propensity Score Weighted Cohort of Czech Registry
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis
Oncologist
Cancer Research
Medicine
Oncology
Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Colorectal Cancer Screening Based on Age and Gender: A Cost-Effectiveness Analysis
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
The Cost–Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies in Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Systematic Review and Network Meta‐Analysis of Regorafenib and TAS‐102 in Refractory Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
Angiogenesis Genotyping and Clinical Outcome During Regorafenib Treatment in Metastatic Colorectal Cancer Patients
Scientific Reports
Multidisciplinary
A Systematic Review and Meta-Analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer
Anticancer Research
Medicine
Cancer Research
Oncology
Cost Effectiveness of Trifluridine/Tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales
Clinical Colorectal Cancer
Oncology
Gastroenterology
Pcn27 - The Real-World Cost and Effectiveness of Everolimus in Metastatic Breast Cancer in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
